Interaction of Postoperative Morbidity and Receipt of Adjuvant Therapy on Long-Term Survival After Resection for Gastric Adenocarcinoma: Results From the U.S. Gastric Cancer Collaborative

Background Postoperative complications (POCs) can negatively impact survival after oncologic resection. POCs may also decrease the rate of adjuvant therapy completion. We evaluated the impact of complications on gastric cancer survival and analyzed the combined effect of complications and adjuvant t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of surgical oncology 2016-08, Vol.23 (8), p.2398-2408
Hauptverfasser: Jin, Linda X., Sanford, Dominic E., Squires, Malcolm Hart, Moses, Lindsey E., Yan, Yan, Poultsides, George A., Votanopoulos, Konstantinos I., Weber, Sharon M., Bloomston, Mark, Pawlik, Timothy M., Hawkins, William G., Linehan, David C., Schmidt, Carl, Worhunsky, David J., Acher, Alexandra W., Cardona, Kenneth, Cho, Clifford S., Kooby, David A., Levine, Edward A., Winslow, Emily, Saunders, Neil, Spolverato, Gaya, Colditz, Graham A., Maithel, Shishir K., Fields, Ryan C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Postoperative complications (POCs) can negatively impact survival after oncologic resection. POCs may also decrease the rate of adjuvant therapy completion. We evaluated the impact of complications on gastric cancer survival and analyzed the combined effect of complications and adjuvant therapy on survival. Methods We analyzed 824 patients from 7 institutions of the U.S. Gastric Cancer Collaborative who underwent curative resection for gastric adenocarcinoma between 2000 and 2012. POC were graded using the modified Clavien–Dindo system. Survival probabilities were estimated using the method of Kaplan and Meier and analyzed using multivariate Cox regression. Results Median follow-up was 35 months. The overall complication rate was 41 %. The 5-year overall survival (OS) and recurrence-free survival (RFS) of patients who experienced complications were 27 and 23 %, respectively, compared with 43 and 40 % in patients who did not have complications ( p  
ISSN:1068-9265
1534-4681
DOI:10.1245/s10434-016-5121-7